Upper respiratory tract infection and drugs of ingredients of testosterone - a phase IV clinical study of FDA data


Summary:

Upper respiratory tract infection is found among people who take drugs with ingredients of testosterone, especially for people who are male, 50-59 old , have been taking the drugs for 1 - 2 years. This phase IV clinical study is created by eHealthMe based on reports of 40,147 people who have side effects when taking drugs with ingredients of testosterone from the FDA, and is updated regularly.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Androderm, Androgel, Axiron, Fortesta, Natesto, Striant, Sustanon, Testim, Testoderm, Testoderm tts, Testopel, Testosterone, Vogelxo.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.


On Oct, 03, 2022

40,147 people reported to have side effects when taking drugs with ingredients of testosterone.
Among them, 93 people (0.23%) have Upper respiratory tract infection


What is Upper respiratory tract infection?

Upper respiratory tract infection is found to be associated with 2,358 drugs and 1,552 conditions by eHealthMe.

Number of reports submitted per year:

Could drugs with ingredients of testosterone cause Upper respiratory tract infection?

Time on drugs with ingredients of testosterone when people have Upper respiratory tract infection *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 25 %
  • 1 - 2 years: 50 %
  • 2 - 5 years: 25 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Upper respiratory tract infection when taking drugs with ingredients of testosterone *:

  • female: 14.13 %
  • male: 85.87 %

Age of people who have Upper respiratory tract infection when taking drugs with ingredients of testosterone *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 4.41 %
  • 20-29: 0.0 %
  • 30-39: 1.47 %
  • 40-49: 5.88 %
  • 50-59: 60.29 %
  • 60+: 27.94 %

Conditions people have *:

  1. Multiple Myeloma (cancer of the plasma cells): 21 people, 22.58%
  2. High Blood Pressure: 10 people, 10.75%
  3. Pain: 9 people, 9.68%
  4. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 5.38%
  5. Blood Testosterone Decreased: 5 people, 5.38%
  6. Depression: 4 people, 4.30%
  7. Cardiac Disorder: 4 people, 4.30%
  8. High Blood Cholesterol: 4 people, 4.30%
  9. Migraine (headache): 3 people, 3.23%
  10. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 3 people, 3.23%

Other drugs people take *:

  1. Fish Oil: 30 people, 32.26%
  2. Diovan: 27 people, 29.03%
  3. Lyrica: 24 people, 25.81%
  4. Prednisone: 24 people, 25.81%
  5. Prilosec: 24 people, 25.81%
  6. Zometa: 23 people, 24.73%
  7. Neurontin: 22 people, 23.66%
  8. Lasix: 22 people, 23.66%
  9. Aredia: 22 people, 23.66%
  10. Temazepam: 21 people, 22.58%

Other side effects people have besides Upper respiratory tract infection *:

  1. Fatigue (feeling of tiredness): 34 people, 36.56%
  2. Pneumonia: 32 people, 34.41%
  3. Weakness: 31 people, 33.33%
  4. Breathing Difficulty: 30 people, 32.26%
  5. Joint Pain: 27 people, 29.03%
  6. Pain: 27 people, 29.03%
  7. Stress And Anxiety: 26 people, 27.96%
  8. Sinusitis (inflammation of sinus): 26 people, 27.96%
  9. Spinal Osteoarthritis (joint cartilage loss in spine): 25 people, 26.88%
  10. Injury: 24 people, 25.81%

* Approximation only. Some reports may have incomplete information.


How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Drugs with ingredients of testosterone, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on testosterone. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: